Calithera Biosciences, Inc. Gains 60%
Mon, Jun 17, 2024 at 07:12 PM
Calithera Biosciences, Inc. (CALA:NASDAQ) rocketted at $0.02, representing a gain of 60%. From Mon, Jun 03, 2024, the stock recorded 20.00% Up Days and 0.00% Green Days
About Calithera Biosciences, Inc. (CALA:NASDAQ)
Calithera Biosciences Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer.
Top 10 Gainers:
- Mustang Bio, Inc. (MBIO:NASDAQ), 476.92%
- Movella Holdings Inc Com (MVLA:NASDAQ), 75.83%
- Interactive Strength Inc. (TRNR:NASDAQ), 71.33%
- Scinai Immunotherapeutics Ltd. American Depositary Shares (SCNI:NASDAQ), 60.46%
- Calithera Biosciences, Inc. (CALA:NASDAQ), 60%
- Azitra Inc (AZTR:NYSEMKT), 56.53%
- Unico American Corporation (UNAM:NASDAQ), 50%
- Trxade Group, Inc. (MEDS:NASDAQ), 41.28%
- Xponential Fitness Inc. Class A (XPOF:NYSE), 34.25%
- ENDRA Life Sciences Inc. (NDRA:NASDAQ), 34.17%